GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY

被引:0
|
作者
Sever, M. Jensterle [1 ,2 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Endocrinol Diabet & Metab Dis, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
230
引用
收藏
页码:A6 / A6
页数:1
相关论文
共 50 条
  • [41] GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
    Li, Ying
    Zheng, Xuemin
    Tang, Lida
    Xu, Weiren
    Gong, Min
    PEPTIDES, 2011, 32 (06) : 1303 - 1312
  • [42] Impaired Satiety Effect of GLP-1 Agonist in Obesity Is Associated With GLP-1 Resistance in Intestinal Afferent Nerves
    Al-Helaili, Alaa
    Wang, Beini
    Beyak, Michael
    GASTROENTEROLOGY, 2014, 146 (05) : S842 - S842
  • [43] GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
    Pourkarim, Fariba
    Entezari-Maleki, Taher
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2303 - 2304
  • [44] Winning researchers unlocked GLP-1 drugs for obesity
    Phelan, Meagan
    SCIENCE, 2024, 384 (6699) : 968 - 970
  • [45] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
    Gallwitz, B.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
  • [46] Therapies for inter-relating diabetes and obesity - GLP-1 and obesity
    Iepsen, Eva W.
    Torekov, Signe S.
    Holst, Jens J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2487 - 2500
  • [48] Are GLP-1 agonists the answer to our obesity epidemic?
    Dapre, Elizabeth
    BRITISH JOURNAL OF GENERAL PRACTICE, 2023, 73 (733): : 365 - 365
  • [49] Attenuated GLP-1 secretion in obesity: Cause or consequence?
    Ranganath, LR
    Beety, JM
    Morgan, LM
    Wright, JW
    Howland, R
    Marks, V
    GUT, 1996, 38 (06) : 916 - 919
  • [50] GLP-1 peptide analogs for targeting pancreatic beta cells
    Alavi, Seyed Ebrahim
    Shahmabadi, Hasan Ebrahimi
    DRUG DISCOVERY TODAY, 2021, 26 (08) : 1936 - 1943